Why the study?
To evaluate the diagnostic support provided by an automated ultra-high-density mapping algorithm in guiding the ablation of micro-reentrant atrial tachycardias.
Does ultra-high-density mapping with an automated algorithm effectively guide the ablation of micro-reentrant atrial tachycardias in patients eligible for AT ablation?
Does ultra-high-density mapping with an automated algorithm effectively guide the ablation of micro-reentrant atrial tachycardias in patients eligible for AT ablation?
Ultra-high-density mapping with automated algorithms effectively identifies and guides the ablation of rare micro-reentrant atrial tachycardias, yielding satisfactory procedural success and low recurrence rates.
Answers are grounded in this paper and cite their sources.
Low recurrence after ultra-high-density mapping-guided ablation of micro-reentrant ATs supports feasibility; hypothesis-generating and should not yet change practice.
BACKGROUND: Recent advancements in ultra-high-density mapping (UHDM) featuring automated functionalities have enhanced our understanding of micro-reentrant atrial tachycardias (mAT) circuits and the precise localization of the origin. PURPOSE: To evaluate the diagnostic support provided by an automated UHDM algorithm in guiding the ablation of mATs. METHODS: Consecutive patients eligible for AT ablation in 22 Italian centers were prospectively enrolled. All ATs were comprehensively mapped in either the left or right atrium utilizing the RHYTHMIA mapping system. The LUMIPOINT tool was systematically employed to confirm electrogram fragmentation within this defined area. RESULTS: Among 159 ATs analyzed, 97 (61.0%) were identified as macro-reentrant ATs, 50 (31.4%) as focal ATs and 12 (7.5%) as mATs. Concerning the mAT group, the targeted activity was localized in the anterior wall in 4 cases (33.3%), in proximity to PVs in 3 cases (25%), along the left ridge in 2 cases (16.6%), and at the roof, in the free wall and along the CTI in 1 case (8.3%), respectively. Low voltage areas (< 0.1 mV) were detected in all mAT cases and colocalized with the origin site. Over a median of 288 [248-349] days of follow-up, 5 (3.1%) patients suffered from an AT/AF arrhythmia recurrence: 3 (3.1%) were in the MAT group, 1 (2%) in the focal AT and 1 (8.3%) in the mAT group. CONCLUSION: A novel automated algorithm for mAT identification, coupled with ORION catheter, enables mAT description and transcatheter ablation of the localized origin of this rare form of AT results in a satisfactory procedural success rate. TRIAL REGISTRATION: Catheter Ablation of Arrhythmias With High-Density Mapping System in the Real World Practice (CHARISMA). http://clinicaltrials.gov/ Identifier: NCT03793998.
No takes yet. Share an insight, caveat, or question.
Mantovan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: